HIV Drug Resistance Profiles Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil
Latest Information Update: 07 Jul 2022
Price :
$35 *
At a glance
- Drugs Dolutegravir (Primary) ; Lamivudine (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- 03 Jul 2020 New trial record